Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytes. - Wikidata - awgldk - TriplyDB

Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytes.

Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytes.

http://www.wikidata.org/entity/Q36820444

about

Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery Hypericin-bearing magnetic iron oxide nanoparticles for selective drug delivery in photodynamic therapy.Nanotechnology applications in hematological malignancies (Review).A novel human artery model to assess the magnetic accumulation of SPIONs under flow conditions.Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia.Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution Treatment Efficiency of Free and Nanoparticle-Loaded Mitoxantrone for Magnetic Drug Targeting in Multicellular Tumor Spheroids.Nanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing.Nanomedicine applied to cardiovascular diseases: latest developments.Immunological Effects of Iron Oxide Nanoparticles and Iron-based Complex Drug Formulations: Therapeutic Benefits, Toxicity, Mechanistic Insights, and Translational Considerations.Synergistic Combination of Multistage Magnetic Guidance and Optimized Ligand Density in Targeting a Nanoplatform for Enhanced Cancer Therapy.

P2860

Q33596330-11C77C81-A550-4908-9EB0-6A60EC9A3F5D Q34028195-E4466DD3-25F0-46B8-BB22-C4E6EA056A96 Q35863911-7E100934-91E0-493D-B092-96D23D5A0120 Q35934466-9E9B6766-84D4-4DCF-9336-BB890BCE27BE Q37630470-C7031C66-D949-4F44-9F10-3420FF4003F4 Q38286594-66A4937D-81EB-41F3-96D1-2D077AE4C5FD Q38637802-B7B2CA87-BAFB-4B0B-BDFF-F6EB7537DF38 Q38830237-4B197B56-F0F8-4CFB-AA97-9FC5517BBEDD Q38891729-DD171636-EF56-446D-8774-28EB9D393AA8 Q39136197-91F4A733-02FF-465C-8F1E-36057385AB86 Q50153603-0E12AD86-4E4B-487E-9234-381D9A472D12 Q50793556-C3140D92-3B30-4634-8408-1806A16419FF

P2860

Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytes.

http://www.wikidata.org/entity/Q36820444

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytes.

@en

type

label

Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytes.

@en

prefLabel

Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytes.

@en

P1433

Q36820444-511A923B-2DE5-4F08-9A69-46403CFA048E

P1476

Q36820444-70D65AAB-51BA-42E3-B4E3-7BA1BBE6B6FF

P2093

Q36820444-009A5BAB-51AE-4F41-B7B3-FB0FDFD21FB8

Q36820444-078E1A45-D9D3-4095-92A9-81AA3D6BD27F

Q36820444-0CDD5AC9-6D67-441C-B6E4-C1B0A5F5D8AB

Q36820444-0E918D1F-0252-4A24-93A3-41920F001ACA

Q36820444-564EEA32-011A-45A0-BE80-BCB924E4B9EE

Q36820444-56BD780E-1F82-4BF7-9735-FE0F395C7B0D

Q36820444-6E0EAE4F-1EAD-4F0D-AEFF-4B89125C5BC5

Q36820444-9281B772-7C2D-4528-A9C6-157D25894EA7

Q36820444-ABDB9FCD-ED91-400B-BD4C-CCCCF36DB081

Q36820444-C8E37CCD-CFD6-4DEE-98E2-45D16903F0DC

P2860

Q36820444-01FADC2E-5CBA-4261-9ECC-DAE6D419EF32

Q36820444-02B9E1B2-291C-42CB-B504-8415FE9746C0

Q36820444-05084CA2-A706-4904-BE08-BB6F60992364

Q36820444-0C4E8F5D-EB07-43B1-B221-72E4B70E6F1C

Q36820444-0ED58CED-2486-458F-8657-DA5BA7744845

Q36820444-193D1306-8F4A-4941-81B2-6D256F41F806

Q36820444-212AA879-FA6C-4AFF-AFAA-916131CF949F

Q36820444-31E89FA2-BA82-4F54-982B-7461391A22B3

Q36820444-5620254E-4690-40B4-8481-B313298800A5

Q36820444-57BF2982-D685-4EAE-8F31-557A29DA9E0A

P304

Q36820444-FDC54AB5-B149-4C5D-B16E-255BE138A583

P31

Q36820444-A2048705-30C2-4CC8-B279-217134D662F8

P356

Q36820444-0985C1A6-FDC7-462B-943E-3A797D7E6276

P407

Q36820444-A282A2FF-09B4-44B1-9F35-584DCECE2B4B

P433

Q36820444-D774A87D-3064-41BA-B57B-EAC2596D50BD

P478

Q36820444-F96A16B3-7786-485D-B6C7-6FE775103F8A

P577

Q36820444-CFF0A053-FEDC-4CA2-A58E-4A16480020C5

P5875

Q36820444-A500C336-A0F0-434B-BDEF-C6DDA56D7412

P698

Q36820444-4F58E6A5-6307-41D7-81BE-D29694B54120

P921

Q36820444-334D9A23-1F96-4FD0-987D-8359DB529A0F

P932

Q36820444-FA8ECE71-19E4-4D6B-A8E4-B4175347875B

P356

P1433

International Journal of Molecular Sciences

P1476

Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytes.

@en

P2093

Christina Janko

http://www.w3.org/2001/XMLSchema#string

Christine Schorn

http://www.w3.org/2001/XMLSchema#string

Christoph Alexiou

http://www.w3.org/2001/XMLSchema#string

Luis E Munoz

http://www.w3.org/2001/XMLSchema#string

Martin Herrmann

http://www.w3.org/2001/XMLSchema#string

Rainer Tietze

http://www.w3.org/2001/XMLSchema#string

Ricardo Chaurio

http://www.w3.org/2001/XMLSchema#string

Sarah von Löhneysen

http://www.w3.org/2001/XMLSchema#string

Stefan Lyer

http://www.w3.org/2001/XMLSchema#string

Stephan Dürr

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer immunoediting: from immunosurveillance to tumor escape

Antibody therapy of cancer

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Subcellular distribution of the anticancer drug mitoxantrone in human and drug-resistant murine cells analyzed by flow cytometry and confocal microscopy and its relationship to the induction of DNA damage.

Nanoparticles and the immune system

The effect of magnetic nanoparticles of Fe(3)O(4) on immune function in normal ICR mice

Cancer anti-angiogenic therapy.

High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule

Comparison of cellular and nuclear flow cytometric techniques for discriminating apoptotic subpopulations.

P304

7341-7355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS14047341

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236100323

http://www.w3.org/2001/XMLSchema#string

P698

23549268

http://www.w3.org/2001/XMLSchema#string

P921

P932

3645689

http://www.w3.org/2001/XMLSchema#string